Equities research analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a note issued to investors on Tuesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
NASDAQ:SRNE opened at $0.01 on Tuesday. The stock has a fifty day simple moving average of $0.01 and a 200-day simple moving average of $0.03. Sorrento Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.42.
Sorrento Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- Bank Stocks – Best Bank Stocks to Invest In
- AbbVie Stock: A Perfect Dip for Investors to Buy
- What is the S&P 500 and How It is Distinct from Other Indexes
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- ETF Screener: Uses and Step-by-Step Guide
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.